Congenital Mesoblastic Nephroma - 5 Studies Found
Withdrawn |
: Studying Biomarkers in Samples From Younger Patients With Kidney Cancer :
|
Recruiting |
: Study of Kidney Tumors in Younger Patients :
|
Recruiting |
: Study of RXDX-101 in Children With Recurrent or Refractory Solid Tumors and Primary CNS Tumors, With or Without TRK, ROS1, or ALK Fusions :
: 2016-01-04 : Drug: Entrectinib TRKA/B/C, ROS1, and ALK inhibitor |
Recruiting |
: Oral TRK Inhibitor LOXO-101 (Larotrectinib) for Treatment of Advanced Pediatric Solid or Primary Central Nervous System Tumors :
: 2015-12-10 : Drug: LOXO-101 (larotrectinib) Capsules / Liquid Administration |
Active, not recruiting |
: Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom :
|